Zur Info

//////////////////

Key Molecules in Multiple Myeloma Identified

ScienceDaily (Oct. 26, 2010) — New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.

Weiterlesen unter :

www.sciencedaily.com/releases/2010/10/101026121749.htm

////////////////////

Mit freundlichen Grüssen

Joseph

Zur Info

////////////////////////////

Höhere Erfolgsraten bei Knochenmarktransplantationen durch gesteigerte Stammzellwanderung

///////////////////////////

www.journalmed.de/newsview.php?id=31680

/////////////////////////

Mit freundlichen Grüssen

Joseph

Zur Info

Bendamustin bereichert moderne Therapiekonzepte bei NHL, CLL und MM

www.journalonko.de/newsview.php?id=4361

Liebe Grüsse

Joseph

Zur Info

/////////////////////

Celgene Corp. has added a news release to its Investor Relations website.
Title: Continuous Treatment with REVLIMID(R) for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Evaluated by Intergroup Phase III Study(CALGB 100104)

ir.celgene.com/phoenix.zhtml?c=111960&p=irol-news&nyo=0

//////////////////////

Liebe Grüsse

Joseph

Halte gerade Kontakt zu Craig Hofmeister (Forschung bzgl.AR-42)
Leider laufen nur Studien im Mausmodell.
;(

Zur INFO

///////////////////////

HULUC 63

Ein Neuer Ansatz, der doch vielversprechend zu sein scheint

www.xvivo.net/huluc-63/

///////////////////////

Frohe Weihnachten

Joseph